11C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
11C-methionine (MET) has recently emerged as an accurate marker of tumor burden and disease activity in patients with multiple myeloma (MM). This dual-center study aimed at further corroboration of the superiority of MET as positron emission tomography (PET) tracer for staging and re-staging MM, as...
Saved in:
Published in | Theranostics Vol. 7; no. 11; pp. 2956 - 2964 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Sydney
Ivyspring International Publisher
01.01.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!